Surgical Robots Are Important Factors in Advanced Orthopedic Care

Enabling technology sales totaled just over $1.3 billion in 2023, accounting for 2.2% of the orthopedic market, and are expected to grow by 7.5% to slightly exceed $1.4 billion in 2024.

Advancements in enabling technology dovetail with innovations in joint replacement and spine, the two largest segments in orthopedics. Success in spine is particularly tied to robotic-assisted navigation, which the top companies in the segment are prioritizing to remain competitive.

• Stryker recently sold its spine implant business but maintained control of the Mako Spine robot, which is currently in limited market release.
• Globus Medical launched the ExcelsiusHub navigation system in November to provide surgeons with real-time visualization of instrument placement and to reduce their reliance on x-ray imaging during spine surgery.
• Medtronic’s continued growth is fueled in part by the expansion of its AiBLE digital ecosystem.
• Smith+Nephew’s combination of JointVue with the CORI Surgical System for robotic-assisted knee replacement is intended to help the company capitalize on the growing ASC market.
• Zimmer Biomet’s ROSA Shoulder System is the first robot designed for shoulder replacement surgery and will differentiate the company from the competition.
• J&J MedTech’s VELYS Active Robotic-Assisted Spine System provides a glimpse into the next generation of robots that will give surgeons more control in performing safe and effective surgery.

Surgeons still need to fully buy into the potential benefits of enabling technology, but there’s little doubt the systems will continue to spur developments across all segments of orthopedics.

Infographic proudly sponsored by Autocam Medical.

Save Supplier